These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31201784)

  • 1. Percentage of Time in Range 70 to 139 mg/dL Is Associated With Reduced Mortality Among Critically Ill Patients Receiving IV Insulin Infusion.
    Lanspa MJ; Krinsley JS; Hersh AM; Wilson EL; Holmen JR; Orme JF; Morris AH; Hirshberg EL
    Chest; 2019 Nov; 156(5):878-886. PubMed ID: 31201784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time in blood glucose range 70 to 140 mg/dl >80% is strongly associated with increased survival in non-diabetic critically ill adults.
    Krinsley JS; Preiser JC
    Crit Care; 2015 Apr; 19(1):179. PubMed ID: 25927986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glycemic gap upon mortality in critically ill patients with diabetes.
    Lou R; Jiang L; Zhu B
    J Diabetes Investig; 2021 Dec; 12(12):2212-2220. PubMed ID: 34075715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic variability and mortality in critically ill patients: the impact of diabetes.
    Krinsley JS
    J Diabetes Sci Technol; 2009 Nov; 3(6):1292-301. PubMed ID: 20144383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time in blood glucose range 70 to 180 mg/dL and survival rate in critically ill patients: A retrospective cohort study.
    Naraba H; Goto T; Shirakawa T; Sonoo T; Kanda N; Nakano H; Takahashi Y; Hashimoto H; Nakamura K
    PLoS One; 2021; 16(5):e0252158. PubMed ID: 34043681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between Glucose Time in Range in Diabetic and Non-Diabetic Patients and Mortality in Critically Ill Patients.
    Ammar MA; Ammar AA; Wee T; Deshpande R; Band M; Akhtar S
    J Intensive Care Med; 2022 Dec; 37(12):1625-1633. PubMed ID: 35491687
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study.
    Krinsley JS; Egi M; Kiss A; Devendra AN; Schuetz P; Maurer PM; Schultz MJ; van Hooijdonk RT; Kiyoshi M; Mackenzie IM; Annane D; Stow P; Nasraway SA; Holewinski S; Holzinger U; Preiser JC; Vincent JL; Bellomo R
    Crit Care; 2013 Mar; 17(2):R37. PubMed ID: 23452622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus.
    Rady MY; Johnson DJ; Patel BM; Larson JS; Helmers RA
    Mayo Clin Proc; 2005 Dec; 80(12):1558-67. PubMed ID: 16342648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of quality of glycemic control in intensive care patients treated with an insulin infusion at a teaching hospital.
    Gauthier L; Ferguson J; Dubé AI; Nguyen PV; Beauchesne MF; Boutin JM
    Can J Diabetes; 2014 Apr; 38(2):139-43. PubMed ID: 24690509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coefficient of glucose variation is independently associated with mortality in critically ill patients receiving intravenous insulin.
    Lanspa MJ; Dickerson J; Morris AH; Orme JF; Holmen J; Hirshberg EL
    Crit Care; 2014 Apr; 18(2):R86. PubMed ID: 24886864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes.
    Egi M; Bellomo R; Stachowski E; French CJ; Hart GK; Taori G; Hegarty C; Bailey M
    Crit Care Med; 2011 Jan; 39(1):105-11. PubMed ID: 20975552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Basal Plus Versus Sliding Scale Insulin Therapy on Glucose Variability in Critically Ill Patients Without Preexisting Diabetes.
    Webster RE; Belfer JJ; Schmidt KJ
    Ann Pharmacother; 2024 Jun; 58(6):565-571. PubMed ID: 37700565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucometrics in the first week of critical illness and its association with mortality.
    Sundarsingh V; Poddar B; Saran S; Jena SK; Azim A; Gurjar M; Singh RK; Baronia AK
    Med Intensiva (Engl Ed); 2023 Jun; 47(6):326-337. PubMed ID: 36344343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderate glucose control is associated with increased mortality compared with tight glucose control in critically ill patients without diabetes.
    Lanspa MJ; Hirshberg EL; Phillips GD; Holmen J; Stoddard G; Orme J
    Chest; 2013 May; 143(5):1226-1234. PubMed ID: 23238456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computerization of the Yale insulin infusion protocol and potential insights into causes of hypoglycemia with intravenous insulin.
    Marvin MR; Inzucchi SE; Besterman BJ
    Diabetes Technol Ther; 2013 Mar; 15(3):246-52. PubMed ID: 23289409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin infusion therapy in critically ill patients.
    Boutin JM; Gauthier L
    Can J Diabetes; 2014 Apr; 38(2):144-50. PubMed ID: 24690510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of a dynamic insulin infusion algorithm for non critically-ill diabetic patients: A before-after study.
    Montanier N; Bernard L; Lambert C; Pereira B; Desbiez F; Terral D; Abergel A; Bohatier J; Rosset E; Schmidt J; Sautou V; Hadjadj S; Batisse-Lignier M; Tauveron I; Maqdasy S; Roche B
    PLoS One; 2019; 14(1):e0211425. PubMed ID: 30689675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of insulin infusion protocols targeting 110-140 mg/dL in patients after cardiac surgery.
    Magaji V; Nayak S; Donihi AC; Willard L; Jampana S; Nivedita P; Eder R; Johnston J; Korytkowski MT
    Diabetes Technol Ther; 2012 Nov; 14(11):1013-7. PubMed ID: 23046399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Study of Postoperative Glycemic Control with a Standardized Insulin Infusion Protocol after Infrainguinal Bypass and Open Abdominal Aortic Aneurysm Repair.
    Steely AM; Smith L; Callas PW; Nathan MH; Lahiri JE; Stanley AC; Steinthorsson G; Bertges DJ
    Ann Vasc Surg; 2017 Oct; 44():211-220. PubMed ID: 28502888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The optimal blood glucose target in critically ill patient: comparison of two intensive insulin therapy protocols].
    Raurell Torredà M; del Llano Serrano C; Almirall Solsona D; Catalan Ibars RM; Nicolás Arfelis JM
    Med Clin (Barc); 2014 Mar; 142(5):192-9. PubMed ID: 23490488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.